Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radient Pharma, Jaiva form new subsidiary NuVax
NuVax, a clinical stage pharmaceutical company, aims to develop novel immune-gene therapeutics that have the potential to impact and extend the quality of life for cancer patients. Through
NuVax, a clinical stage pharmaceutical company, aims to develop novel immune-gene therapeutics that have the potential to impact and extend the quality of life for cancer patients. Through
As per the terms of the development and commercialisation agreement between the companies, in exchange for exclusive world-wide rights to commercialise specific products based on Mesoblast’s proprietary adult
GLYX-13 is Naurex’s lead glycine-site functional partial agonist (GFPA) selective modulator of the NMDA receptor. The novel GFPA class of compounds has been specifically designed to achieve the
Under the terms of the expanded agreement, Dicerna will receive a cash payment for exercise by Kyowa Hakko Kirin of an option to bring an additional target into
Ancora Pharma said that each eligible project was awarded approximately $244,000 through the program. The National Institutes of Health grants were awarded to projects with potential to result
Abacavir Sulfate tablets are used in combination with other medications to control HIV infection and is included in the ARV class of drugs known as nucleoside reverse transcriptase
Zogenix and Desitin Pharma claim Sumavel DosePro offers fast acting, easy-to-use, needle-free subcutaneous administration of sumatriptan. Sumavel DosePro may offer a treatment alternative to oral and nasal triptans,
The integration helps to enable complete real-time patient electronic medical records (EMRs) at the Canadian Healthcare facility. Streamline Health’s integrated solution is designed to deliver improved efficiencies by
The license includes a carve-out by BIG for use of the technology in its non-Hodgkin lymphoma (NHL) vaccine which is currently under development. The license leaves Stellar free
Orbus Pharma’s Cambridge facility is an antibiotics facility which has the current capacity of >50 million capsules or tablets per year with existing equipment. The purchase price of